Raloxifene and body composition and muscle strength in postmenopausal women: A randomized, double-blind, placebo-controlled trial

European Journal of Endocrinology

Volumn 162, Issue 2, 2010, Pages 371-376

  Jacobsen, Didy E ^a   Samson, Monique M ^a   Emmelot Vonk, Marielle H ^a   Verhaar, Harald J J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

RALOXIFENE;

AGED; AGING; ARTICLE; BODY COMPOSITION; BODY MASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; FLUSHING; GRIP STRENGTH; HUMAN; HUMAN EXPERIMENT; KNEE; LEG; LEG CRAMP; MUSCLE ISOMETRIC CONTRACTION; MUSCLE STRENGTH; NETHERLANDS; NORMAL HUMAN; PATIENT COMPLIANCE; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TOTAL BODY WATER;

AGED; AGED, 80 AND OVER; BODY COMPOSITION; BONE DENSITY CONSERVATION AGENTS; DOUBLE-BLIND METHOD; FEMALE; HAND STRENGTH; HUMANS; ISOMETRIC CONTRACTION; MUSCLE STRENGTH; OSTEOPOROSIS, POSTMENOPAUSAL; RALOXIFENE; RESIDENCE CHARACTERISTICS;

EID: 75149182867     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-09-0619     Document Type: Article

References (40)

1. Samson MM, Meeuwsen IBAE, Crowe A, Dessens JAG, Duursma SA & Verhaar HJJ. Differences in variables of muscle strength and functional mobility in healthy subjects in relation to age, height and body weight. Age and Ageing 2000 29 235-242.
2. Kallman DA, Plato CC & Tobin JD. The role of muscle loss in the age-related decline of grip strength: cross-sectional and longitudinal perspectives. Journal of Gerontology 1990 45 M82-M88.
3. Panotopoulos G, Raison J, Ruiz JC, Guy-Grand B & Basdevant A. Weight gain at the time of menopause. Human Reproduction 1997 12 126-133.
4. Di Carlo C, Tommaselli GA, Sammantino A, Bifulco G, Nasti A & Nappi C. Serum leptin levels and body composition in postmenopausal women: effects of hormone therapy. Menopause 2004 11 466-473.
5. Lapidus L, Bengtsson C, Larsson B, Pennert K, Rybo E & Sjostrom L. Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow-up of participants in the population study of women in Gothenburg, Sweden. BMJ 1984 289 1257-1261.
6. Hoover LW & Boote EJ. Londitudinal assessment of intra-abdominal fat in postmenopausal women. Annals of the New York Academy of Sciences 2000 904 520-525.
7. Hagberg JM, Zmuda JM, McCole SD, Rodgers KS, Wilund KR & Moore GE. Determinants of body composition in postmenopausal women. Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2000 55 M607-M612.
8. Phillips SK, Rook KM, Siddle NC, Bruce SA & Woledge RC. Muscle weakness in women occurs at an earlier age than in men, but strength is preserved by hormone replacement therapy. Clinical Science 1993 84 95-98.
9. Cauley JA, Robbins J, Chen Z, Cummings SR, Jackson RD, La Croix AZ, LeBoff M, Lewis CE, McGowan J, Neuner J, Pettinger M, Stefanick ML, Wactawski-Wende J & Watts NB. Effects of estrogen plus progestin on risk of fracture and bone mineral density: the women health initiative randomized trial. Journal of the American Medical Association 2003 290 1729-1738.
10. Taaffe DR, Sipilä S, Cheng S, Puolakka J, Toivanen J & Suominen H. The effect of hormone replacement therapy and/or exercise on skeletal muscle attenuation in postmenopausal women: a year long intervention. Clinical Physiology and Functional Imaging 2005 25 297-304.
11. Heikkinen J, Kyllonen E, Kurtilla-Matero E, Willen-Rosenqvist G, Lankinen KS, Rita H & Vaananen HK. HRT and exercise: effects on bone density, muscle strength and lipid metabolism. A placebo controlled 2 year prospective trial on two estrogen-progestin regimens in healthy postmenopausal women. Maturitas 1997 26 139-149.
12. Sipila S, Taaffe DR, Cheng S, Puolakka J, Toivanen J & Suominen H. Effects of hormone replacement therapy and high impact physical exercise on skeletal muscle in post-menopausal women: a randomized placebo-controlled study. Clinical Science 2001 101 147-157.
13. Skelton DA, Phillips SK, Bruce SA, Nayor CH & Woledge RC. Hormone replacement therapy increases isometric muscle strength of adductor pollicis in post-menopausal women. Clinical Science 1999 96 357-364.
14. Brooke-Wavell K, Prelevic GM, Bakridan C & Ginsburg J. Effects of physical activity and menopausal hormone replacement therapy on postural stability in postmenopausal women - a cross-sectional study. Maturitas 2001 37 167-172.
15. Greeves JP, Cable NT, Reilly T & Kingsland C. Changes in muscle strength in women following the menopause: a longitudinal assessment of the efficacy of hormone replacement therapy. Clinical Science 1999 97 79-84.
16. Writing Group for the Women's Health Initiative Investigators (2002). Risk and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial. Journal of the American Medical Association 2002 288 321-333.
17. Khovidhunkit W & Shoback DM. Clinical review. Clinical effects of raloxifene hydrochloride in women. Annals of Internal Medicine 1999 130 431-439.
18. Ott SM, Oleksik A, Lu Y, Harper K & Lips P. Bone histomorphometric and biochemical marker results of a 2-year placebo-controlled trial of raloxifene in postmenopausal women. Journal of Bone and Mineral Research 2002 17 341-348.
19. Tommaselli GA, Di Carlo C, Di Spiezo Sardo A, Bifulco G, Cirillo D, Guida M, Capasso R & Nappi C. Serum leptin levels and body composition in postmenopausal women treated with tibolone and raloxifene. Menopause 2006 13 660-668.
20. Lee CC, Kasa-Vubu JZ & Supiano MA. Differential effects of raloxifene and estrogen on insulin sensitivity in postmenopausal women. Journal of American Geriatric Society 2003 51 683-688.
21. Jacobsen DE, Samson MM, Schouw YT, Grobbee DE & Verhaar HJJ. Efficacy of tibolone and raloxifene for the maintenance of skeletal muscle strength, bone mineral density, balance, body composition, cognitive function, mood/depression, anxiety and quality of life/well-being in late postmenopausal women ≥70 years: study design of a randomized, double-blind, double-dummy, placebo-controlled, single-center trial. Trials 2008 9 32.
22. Brummer RJM, Rosén T & Bengtsson B-Å. Evaluation of different methods for determing body composition, with special reference to growth hormone-related disorder. Acta Endocrinologica 1993 128 30-36.
23. Xie X, Kolthoff N, Barenholt O & Nielsen SP. Validation of a leg-to-leg bio-impedance analysis system in assessing body composition in postmenopausal women. International Journal of Obesity and Related Metabolic Disorders 1999 23 1079-1084.
24. Pasquali R, Vicennati V, Bertazzo D, Casimirri F, Pascal G, Tortelli O & Labate AM. Determinants of sex hormone-binding globulin blood concentrations in premenopausal and postmenopausal women with different oestrogen status. Virgilio-Menopause-Health Group. Metabolism 1997 46 5-9.
25. Lukaski HC, Bolonchuk WW, Hall CB & Siders W. Validation of tetrapolar bioelectrical impedance method to assess human body composition. Journal of Applied Physics 1986 60 1327-1332.
26. Segal KR, Gutin B, Presta E, Wang J & van Itallie T. Estimation of human body composition by electrical impedance methods: a comparative study. Journal of Applied Physics 1985 58 1565-1571.
27. Snel YEM. Growth hormone deficiency in adults. Body composition, energy metabolism and effects of growth hormone replacement therapy. Thesis University Utrecht, The Netherlands 1995. Schiedam: Steens.
28. Kotler DP, Burastero S,Wang J & Peirson RN Jr. Prediction of body cell mass, fat-free mass, and total body water with bioelectrical impedance analysis: effects of race, sex, and disease. American Journal of Clinical Nutrition 1996 64 489S-497S.
29. Segal KR, Van Loan M, Fitzgerald PI, Hodgdon JA & Van Itallie TB. Lean body mass estimation by bioelectrical impedance analysis: a four site cross-validation study. American Journal of Clinical Nutrition 1988 47 7-14.
30. Edwards RHT, Young A, Hosking GP & Jones DA. Human skeletal muscle function: description of tests and normal values. Clinical Science & Molecular Medicine 1977 52 283-290.
31. Höök O & Tornvall G. Apparatus and method for determination of isometric muscle strength. Scandinavian Journal of Rehabilitation 1969 1 139-142.
32. Bassey EJ & Short AH. A new method for measuring power output in a single leg extension: feasibility, reliability and validity. European Journal of Applied Physiology 1990 60 385-390.
33. Anderson WF & Cowan NR. Handgrip pressure in older people. British Journal of Preventive and Social Medicine 1966 20 141-147.
34. Lindsay R, Cosman F, Herrington BS & Himmelstein S. Bone mass and body composition in normal women. Journal of Bone and Mineral Research 1992 7 55-63.
35. Bergstrom A, Pisani P, Tenet V, Wolk A & Adami HO. Overweight as an avoidable cause of cancer in Europe. International Journal of Cancer 2001 91 421-430.
36. Morley JE, Baumgartner RN, Roubenoff R, Mayer J & Nair KS. Sarcopenia. Journal of Laboratory and Clinical Medicine 2001 137 231-293.
37. Francucci CM, Daniele P, Iori N, Camiletti A, Massi F & Boscaro M. Effects of raloxifene on body fat distribution and lipid profile in healthy post-menopausal women. Journal of Endocrinological Investigation 2005 28 623-631.
38. Ribom EL, Piehl-Aulin K, Ljunghall S, Ljunggren Ö & Naessén T. Six months of hormone replacement therapy does not influence muscle strength in postmenopausal women. Science Direct 2002 42 225-237.
39. Armstrong AL, Oborne J, Coupland CAC, Macpherson MB, Bassey EJ & Wallace WA. Effects of hormone replacement therapy on muscle performance and balance in post-menopausal women. Clinical Science 1996 91 685-690.
40. Nijland EA, Weijmar Schultz WCM & Davis SR. Effects of tibolone and raloxifene on health-related quality of life and sexual function. Maturitas 2007 58 164-173.